Sunday, March 3, 2019

Top Clean Energy Stocks To Invest In Right Now

tags:SIG,PMO,DVAX, Apple does not agree with the Trump Administration on a number of issues, including tariffs and immigration. Now the iPhone maker is speaking out about the dangers of rolling back environmental protections.

Lisa Jackson, Apple's vice president of environment, policy and social initiatives, gave a speech that covered what the company considers the dangers of the federal government's environmental policies at the Global Climate Action Summit in San Francisco on Thursday.

"Just a few weeks ago, the administration announced that they plan to roll back nationwide clean energy standards. The new plan risks drastically increasing emissions over the next 20 years," said Jackson.

It was the latest move by the federal government to roll back environmental protections and safeguards enacted under the Obama administration.

The Trump administration thinks the regulatory costs of the rules stifle businesses.

Jackson, who was the head of the Environmental Protection Agency for four years under President Barack Obama, said those policies were already demonstrating real results.

Top Clean Energy Stocks To Invest In Right Now: Signet Jewelers Limited(SIG)

Advisors' Opinion:
  • [By Joseph Griffin]

    Luk Fook Holdings (International) (OTCMKTS: LKFLF) and Signet Jewelers (NYSE:SIG) are both mid-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Signet Jewelers (SIG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Signet Jewelers (SIG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Clean Energy Stocks To Invest In Right Now: Putnam Municipal Opportunities Trust(PMO)

Advisors' Opinion:
  • [By Stephan Byrd]

    News coverage about Putnam Municipal Opportunities Trust (NYSE:PMO) has trended positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Putnam Municipal Opportunities Trust earned a coverage optimism score of 0.36 on Accern’s scale. Accern also gave media stories about the financial services provider an impact score of 44.4937566813447 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Ethan Ryder]

    Headlines about Putnam Municipal Opportunities Trust (NYSE:PMO) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Putnam Municipal Opportunities Trust earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 45.534048831996 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top Clean Energy Stocks To Invest In Right Now: Dynavax Technologies Corporation(DVAX)

Advisors' Opinion:
  • [By Ethan Ryder]

    Dynavax Technologies (NASDAQ:DVAX)‘s stock had its “buy” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday. They presently have a $27.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 67.70% from the stock’s current price.

  • [By George Budwell]

    After a rather tumultuous 2018 campaign, shares of Dynavax Technologies (NASDAQ:DVAX) regained their footing last month by gaining a noteworthy 20.4%, according to data from S&P Global Market Intelligence. The catalyst?

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Dynavax Technologies (DVAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Dynavax Technologies alerts: Dynavax Technologies Co. (DVAX) Receives Average Recommendation of “Buy” from Brokerages (americanbankingnews.com) Earnings per share (EPS) in the Spotlight – Dynavax Technologies Corporation (NASDAQ: DVAX) (stocksmarketcap.com) Is the Stock Safe to Invest? – Dynavax Technologies Corporation (NASDAQ:DVAX) (nasdaqjournal.com) Investor’s Watch List: Dynavax Technologies Corporation (DVAX) (nasdaqplace.com) You Need to Watch this stock? Dynavax Technologies Corporation (DVAX) (connectinginvestor.com)

    DVAX has been the topic of several analyst reports. Cantor Fitzgerald set a $27.00 price objective on Dynavax Technologies and gave the company a “buy” rating in a research note on Wednesday, May 16th. ValuEngine lowered Dynavax Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, May 1st. BidaskClub downgraded Dynavax Technologies from a “buy” rating to a “hold” rating in a report on Sunday, April 22nd. Finally, JPMorgan Chase & Co. raised Dynavax Technologies from a “neutral” rating to an “overweight” rating and set a $25.00 target price on the stock in a report on Thursday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. Dynavax Technologies currently has a consensus rating of “Buy” and an average target price of $24.67.

  • [By George Budwell]

    Shares of immuno-oncology and next-generation vaccine-maker Dynavax Technologies Corporation (NASDAQ:DVAX) lost 10.5% of their value in September, according to data from S&P Global Market Intelligence. What went wrong for the drugmaker last month?

No comments:

Post a Comment